GLAD and BioResource highlighted in government clinical research strategy

New government guidance on the future of clinical research lists the BioResource as one of its data assets, highlighting GLAD as one of the case studies

The new government guidance 'Saving and improving lives: the future of UK clinical research delivery' acknowledges the tireless efforts of healthcare professionals, researchers, participants, regulators, medical charities and industry who have helped to lead the world in COVID-19 research.

The contribution to COVID-19 research has helped to improve healthcare and save lives all over the UK and across the globe.

Today’s major healthcare challenges require an increased commitment to clinical research.  These challenges include the rise in long-term conditions such as obesity, diabetes and mental health. For example the Genetic Links to Anxiety and Depression (GLAD) study (part of the Mental Health BioResource) aims to find out how genes and our environment act together to bring about anxiety and depression.  Then to identify effective treatments and improve the lives of people experiencing these conditions.

Clinical research is all around us and helps to improve the quality of healthcare patients receive

The aim is to have clinical research at the heart of patient care across the NHS. To make participation as easy as possible and to ensure all health and care staff feel empowered to support research.  

The government vision is for the UK to have the most advanced and data-enabled clinical research environment in the world.    Where the nation's unique data assets [including the NIHR BioResource] can be used to deliver improvements to the health and care of patients across the UK and beyond.



Saving and improving lives: the future of UK clinical research delivery - GOV.UK

Published 23 March 2021